Fundraising Fox

Anumana

Cambridge, US · Founded 2020 · Delaware corporation · 1 known investors

anumana.ai

Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making. Its portfolio includes FDA-cleared ECG-AI algorithms, generative imaging applications, and real-time procedural support tools for use across diagnostic and intraprocedural cardiac care.

AI & Machine LearningBiotechDigital HealthMedical Devices

Founders & leadership

Anumana was founded in 2020 by Murali Aravamudan.

MAMurali Aravamudan
Murali AravamudanFounder
HF
Harris FishmanNamed on SEC filing
AC
Alan ColowickNamed on SEC filing
CR
Cheranjit RihalNamed on SEC filing
DG
David GoelNamed on SEC filing
KB
Kyle BettigoleNamed on SEC filing
MN
Maulik NanavatyCEO

Investors · 1

Reported raises · per SEC filings

Form D private placements

$32M disclosed across 1 round · 2022

$32MraisedNov 2022 · 72 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Murali AravamudanExecutive Officer, Director
  • Harris FishmanExecutive Officer
  • Alan ColowickDirector
  • Cheranjit RihalDirector
  • David GoelDirector
  • Kyle BettigoleExecutive Officer
Offering amount
$32M
Amount sold
$32M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Anumana for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Anumana do?
Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making. Its portfolio includes FDA-cleared ECG-AI algorithms, generative imaging applications, and real-time procedural support tools for use across diagnostic and intraprocedural cardiac care.
Who founded Anumana?
Anumana was founded by Murali Aravamudan in 2020.
Who are Anumana's investors?
Anumana's investors include NTT Venture Capital.
How much funding has Anumana raised?
Anumana has disclosed $32M raised across 1 round.
Where is Anumana headquartered?
Anumana is headquartered in Cambridge, US.